• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Benitec Biopharma Ltd

+ Add to Watchlist

BJ9:GR

0.567 EUR 0.009 1.56%

As of 15:16:21 ET on 12/23/2014.

Snapshot for Benitec Biopharma Ltd (BJ9)

Open: 0.565 Day's Range: 0.565 - 0.573 Volume: 0
Previous Close: 0.576 52wk Range: 0.362 - 1.550 1-Yr Rtn: +52.83%

Stock Chart for BJ9

No chart data available.
  • BJ9:GR 0.565
  • 1D
  • 1M
  • 1Y
0.576
Interactive BJ9 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BJ9

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. DAX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2015) -0.0270
Est. PEG Ratio -
Market Cap (M EUR) 65.52
Shares Outstanding (M) 115.56
30 Day Average Volume 2,798
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BJ9

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for BJ9

Benitec Biopharma Ltd. is a medical technology research and development Company. The Company's research focuses on the gene-technology field to find ways to fight cancer causing cells. Benitec's research encompasses a gene silencing technology in mammalian cells.

Peter FrenchCEO/Managing DirectorMichael W GrahamChief Scientific Officer
Carl S StubbingsChief Business OfficerDavid SuhySenior VP:Rsch & Dev
More Company Profile & Key Executives for BJ9

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil